Building 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX
Company Size
51-200 employees
Founded
2016
Categories
Research and experimental development on biotechnology
Visa Information
Licensed Visa Types
skilled worker
Annual Issuance Trend
About
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures and British Patient Capital.
Suggest an edit
Claim this company
Jobs (~3 days delayed) in Oxford, England, United Kingdom
You're seeing delayed jobs. Sign up free to unlock fresh jobs.
No jobs found
Try adjusting your search filters or criteria
Frequently Asked Questions about OMass Therapeutics Limited